CLOV Clover Health Investments Corp

Price (delayed)

$0.695

Market cap

$344.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

$226.03M

Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral ...

Highlights
The gross profit has surged by 128% year-on-year and by 21% since the previous quarter
Clover Health Investments's gross margin has increased by 44% QoQ
The revenue has contracted by 42% YoY and by 16% from the previous quarter
The equity has contracted by 20% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of CLOV
Market
Shares outstanding
495.29M
Market cap
$344.23M
Enterprise value
$226.03M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
0.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.11
Earnings
Revenue
$2.03B
EBIT
-$213.35M
EBITDA
-$210.85M
Free cash flow
-$116.46M
Per share
EPS
-$0.44
Free cash flow per share
-$0.24
Book value per share
$0.59
Revenue per share
$4.22
TBVPS
$1.18
Balance sheet
Total assets
$570.67M
Total liabilities
$284.28M
Debt
$4.66M
Equity
$286.39M
Working capital
$166.86M
Liquidity
Debt to equity
0.02
Current ratio
1.64
Quick ratio
1.28
Net debt/EBITDA
0.56
Margins
EBITDA margin
-10.4%
Gross margin
13%
Net margin
-10.5%
Operating margin
-10.3%
Efficiency
Return on assets
-19.7%
Return on equity
-67.6%
Return on invested capital
-224.2%
Return on capital employed
-68.9%
Return on sales
-10.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CLOV stock price

How has the Clover Health Investments stock price performed over time
Intraday
8.59%
1 week
2.21%
1 month
-8.15%
1 year
-9.08%
YTD
-27%
QTD
-12.47%

Financial performance

How have Clover Health Investments's revenue and profit performed over time
Revenue
$2.03B
Gross profit
$264.57M
Operating income
-$208.54M
Net income
-$213.36M
Gross margin
13%
Net margin
-10.5%
The gross profit has surged by 128% year-on-year and by 21% since the previous quarter
Clover Health Investments's gross margin has increased by 44% QoQ
The operating income has grown by 44% YoY and by 17% from the previous quarter
The revenue has contracted by 42% YoY and by 16% from the previous quarter

Growth

What is Clover Health Investments's growth rate over time

Valuation

What is Clover Health Investments stock price valuation
P/E
N/A
P/B
1.18
P/S
0.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.11
CLOV's EPS is up by 38% year-on-year and by 6% since the previous quarter
The P/B is 21% below the last 4 quarters average of 1.5
The equity has contracted by 20% YoY and by 11% from the previous quarter
The revenue has contracted by 42% YoY and by 16% from the previous quarter
The P/S is 20% below the last 4 quarters average of 0.2

Efficiency

How efficient is Clover Health Investments business performance
The return on invested capital has declined by 27% year-on-year and by 11% since the previous quarter
CLOV's ROE is up by 17% YoY
CLOV's return on sales is down by 12% since the previous quarter and by 8% year-on-year
The ROA has contracted by 3.1% YoY

Dividends

What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLOV.

Financial health

How did Clover Health Investments financials performed over time
CLOV's total assets is 101% greater than its total liabilities
Clover Health Investments's total liabilities has plunged by 61% from the previous quarter and by 37% YoY
CLOV's total assets is down by 46% since the previous quarter and by 29% year-on-year
The debt is 98% less than the equity
The debt has contracted by 20% YoY and by 6% from the previous quarter
The equity has contracted by 20% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.